David Alanby Johnson

David Alanby Johnson is a Regulatory Affairs Portfolio Director specializing in Haematology at AstraZeneca, where they focus on Regulatory Metrics and Compliance. With approximately 28 years of experience, they have previously held significant roles at COMPETIRA LTD. as Company Director, and Gilead Sciences as Associate Manager, managing various regulatory activities for major biopharmaceutical products. Their extensive background also includes positions at Genzyme Europe BV and Mundipharma, where they led regulatory initiatives across multiple regions. Johnson earned a degree in Pharmacology with Basic Medical Sciences from Queen Mary University of London.